Millennium Research & Clinical Development (Site 0039)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Recruiting

  A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  NCT06312137· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Toll Free Number